Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Autor: Banerji, Udai, van Herpen, Carla M L, Saura, Cristina, Thistlethwaite, Fiona, Lord, Simon, Moreno, Victor, Macpherson, Iain R, Boni, Valentina, Rolfo, Christian, de Vries, Elisabeth G E, Rottey, Sylvie, Geenen, Jill, Eskens, Ferry, Gil-Martin, Marta, Mommers, Ellen C, Koper, Norbert P, Aftimos, Philippe
Zdroj: In The Lancet Oncology August 2019 20(8):1124-1135
Databáze: ScienceDirect